What approaches can pharmacists embrace to more effectively adapt to the rapidly changing landscape of U.S. health care? It’s exactly this question that Philip E. Johnson, RPh, FASHP, the oncology director for Premier, Inc, a health care improvement company, explores in the December edition of Pharmacy Practice News:
“Protecting oncology drug–related revenue is a good place to start, given the huge dollar figures involved and the ease with which that revenue can slip from an institution’s grasp, said Mr. Johnson, who was previously the director of pharmacy at the Moffitt Cancer Center in Tampa, Fla. ‘Revenue is not a four-letter word. It’s important. If the doors close, we’re not providing care to anybody.'”
Click here to read the full article (“Reimbursement and Revenue Integrity”) by Susan Birk and see what tips Mr. Johnson offers to help pharmacists improve efficiencies and communicate their message to leaders, stakeholders and payers alike.